|
Share:

Equipped with an array of the industry’s most state-of-the-art equipment and latest procedures, the experienced team at Long Island Dental Sleep Medicine (LIDSM) is at the vanguard of dental offices combating the dangers associated with obstructive sleep apnea.

L–R: Jeffrey S. Rein, DDS, FAGD, D.ABDSM, D.ACSDD, D.ASBA, and Neal Seltzer, DMD, FAGD, D.ABDSM, D.ACSDD, D.ASBA, of Long Island Dental Sleep Medicine LIDSM has been treating patients successfully with oral appliance therapy for more than 25 years. Led by Neal Seltzer, DMD, FAGD, and Jeffrey S. Rein, DDS, FAGD — both Diplomates of the American Board of Dental Sleep Medicine, Academy of Clinical Sleep Disorder Disciplines, and the American Sleep and Breathing Academy — LIDSM is the first office in the state of New York to attain a Dental Sleep Medicine Accreditation from the Academy of Dental Sleep Medicine.

Earning the title of “Dental Sleep Medicine Accredited Facility” places LIDSM amid an elite group of practices around the country recognized for their excellence in care and professionalism in treating patients with obstructive sleep apnea (OSA). To become accredited by the Academy of Dental Sleep Medicine, facilities must meet stringent standards for their dentists, staff, policies, procedures, care, treatment, billing, follow-up and safety.

“The goal is rather simple: to provide our patients with the best care we possibly can,” Dr. Seltzer says. “Although it took many years of hard work to achieve, this accreditation will put us in a position to provide better outcomes for those suffering from the very serious condition of sleep apnea.”

The MATRx Diagnostic System

Trying to predict if a patient will benefit from oral appliance therapy has been a challenge for dentists over the years. Without the latest technology, dentists have had to rely on careful clinical observations, analysis of anatomy, sleep studies and detailed medical histories to choose a particular appliance and ensure its careful placement and fitting.

While there is still no single measuring device capable of absolutely predicting if a patient will respond favorably to oral appliance therapy, technology has given rise to a new tool that can improve the chances of a successful prediction: the MATRx.

Developed by Zephyr, the MATRx system is used for in-lab titration prior to actually fabricating a final custom oral appliance for patients. Once a patient is diagnosed with OSA, a MATRx test will enable a physician to confidently prescribe oral appliance therapy that will be effective.

“We are proud to be one of the few dental offices in the country trained in the use of the MATRx system,” says Dr. Seltzer. “So far, Long Island Dental Sleep Medicine has helped institute the MATRx into several area hospital-based sleep centers. Together, we are breaking new ground in our ability to predict success early.”

Read the Full Article

Related Articles